REGENERON PHARMACEUTICALS, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Tarrytown, NY
SEC filing record 1 source field available
Fiscal year end
31 December
REGENERON PHARMACEUTICALS, INC. has filed 2,452 SEC EDGAR filings since 26 Jul 1995

SEC filing history

Showing 351-375 of 1,000 matching filings.

Per page
25
Current page
15
4

PRIMARY DOCUMENT

Filing date
03 Aug 2023
Reporting date
01 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Aug 2023
Reporting date
01 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19034

144 filing

Filing date
01 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
06 Jul 2023
Reporting date
03 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
06 Jul 2023
Reporting date
03 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19034

144 filing

Filing date
03 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19034

144 filing

Filing date
03 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
02 Jun 2023
Reporting date
01 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
02 Jun 2023
Reporting date
01 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19034

144 filing

Filing date
01 Jun 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PX14A6G File 000-19034

PX14A6G filing

Filing date
18 May 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 May 2023
Reporting date
15 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 000-19034

DEFA14A

Filing date
17 May 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
10 May 2023
Reporting date
09 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 May 2023
Reporting date
01 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
24 Apr 2023
Reporting date
21 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19034

144 filing

Filing date
21 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 000-19034

ARS

Filing date
21 Apr 2023
Reporting date
31 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 000-19034

REGENERON PHARMACEUTICALS, INC. - DEFA14A

Filing date
21 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-19034

REGENERON PHARMACEUTICALS, INC. - DEF 14A

Filing date
21 Apr 2023
Reporting date
Not listed
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .